Nektar Therapeutics
NKTR
NASDAQ
IPO1994
about NKTR
Nektar Therapeutics is a biopharmaceutical company dedicated to advancing innovative medicines through its proprietary PEGylation platform, focusing on treatments for chronic pain and oncology.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $47.15 | $56.76 | $47.05 | $754.06M | 8.70M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$1.87 | n/a | 92.50 | -268.63% | -301.29% | 0% |